Equities analysts expect that Allstate Corp (NYSE:ALL) will post sales of $8.43 billion for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for Allstate’s earnings. The lowest sales estimate is $8.35 billion and the highest is $8.48 billion. Allstate reported sales of $9.28 billion in the same quarter last year, which would suggest a negative year over year growth rate of 9.2%. The firm is expected to announce its next earnings results after the market closes on Wednesday, February 7th.

According to Zacks, analysts expect that Allstate will report full-year sales of $8.43 billion for the current year, with estimates ranging from $33.52 billion to $33.65 billion. For the next fiscal year, analysts expect that the business will report sales of $34.46 billion per share, with estimates ranging from $34.16 billion to $34.66 billion. Zacks’ sales calculations are an average based on a survey of research analysts that cover Allstate.

Allstate (NYSE:ALL) last issued its quarterly earnings data on Wednesday, November 1st. The insurance provider reported $1.60 EPS for the quarter, missing the Zacks’ consensus estimate of $1.61 by ($0.01). The company had revenue of $8.12 billion for the quarter, compared to the consensus estimate of $8.07 billion. Allstate had a return on equity of 13.11% and a net margin of 7.32%. Allstate’s quarterly revenue was up 3.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.26 earnings per share.

A number of research analysts recently commented on the company. Wells Fargo & Co restated a “buy” rating and set a $105.00 price objective on shares of Allstate in a research note on Thursday, November 2nd. Zacks Investment Research upgraded Allstate from a “hold” rating to a “buy” rating and set a $115.00 price objective for the company in a research note on Tuesday, December 12th. B. Riley restated a “neutral” rating on shares of Allstate in a research note on Monday, November 6th. UBS Group lowered their price objective on Allstate from $94.00 to $93.00 and set a “neutral” rating for the company in a research note on Tuesday, September 19th. Finally, Credit Suisse Group upped their price objective on Allstate from $91.00 to $95.00 and gave the stock a “neutral” rating in a research note on Thursday, November 2nd. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $96.43.

Shares of Allstate (ALL) traded up $1.33 on Friday, reaching $102.11. The company had a trading volume of 2,397,212 shares, compared to its average volume of 1,661,025. The company has a market cap of $36,162.48, a P/E ratio of 14.18, a P/E/G ratio of 1.52 and a beta of 1.12. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.26 and a current ratio of 0.26. Allstate has a 52-week low of $73.13 and a 52-week high of $105.36.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, January 2nd. Shareholders of record on Thursday, November 30th were given a dividend of $0.37 per share. The ex-dividend date was Wednesday, November 29th. This represents a $1.48 dividend on an annualized basis and a yield of 1.45%. Allstate’s dividend payout ratio (DPR) is presently 20.56%.

In other Allstate news, CEO Thomas J. Wilson sold 130,000 shares of the business’s stock in a transaction on Wednesday, November 8th. The stock was sold at an average price of $99.29, for a total transaction of $12,907,700.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Susan L. Lees sold 4,000 shares of the business’s stock in a transaction on Monday, November 20th. The stock was sold at an average price of $100.49, for a total value of $401,960.00. Following the transaction, the executive vice president now owns 24,341 shares of the company’s stock, valued at approximately $2,446,027.09. The disclosure for this sale can be found here. Insiders have sold a total of 432,242 shares of company stock valued at $42,827,931 in the last quarter. 1.58% of the stock is currently owned by insiders.

A number of hedge funds have recently made changes to their positions in the business. Arrow Financial Corp lifted its holdings in shares of Allstate by 100.0% in the third quarter. Arrow Financial Corp now owns 1,106 shares of the insurance provider’s stock valued at $102,000 after buying an additional 553 shares during the period. Sandy Spring Bank lifted its holdings in shares of Allstate by 2.5% in the second quarter. Sandy Spring Bank now owns 1,165 shares of the insurance provider’s stock valued at $103,000 after buying an additional 28 shares during the period. IHT Wealth Management LLC lifted its holdings in shares of Allstate by 46.6% in the second quarter. IHT Wealth Management LLC now owns 1,275 shares of the insurance provider’s stock valued at $113,000 after buying an additional 405 shares during the period. Financial Engines Advisors L.L.C. acquired a new stake in shares of Allstate in the third quarter valued at $116,000. Finally, Baker Ellis Asset Management LLC acquired a new stake in shares of Allstate in the third quarter valued at $120,000. Institutional investors own 76.43% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “$8.43 Billion in Sales Expected for Allstate Corp (ALL) This Quarter” was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this story on another domain, it was stolen and republished in violation of international copyright and trademark legislation. The legal version of this story can be viewed at https://www.americanbankingnews.com/2018/01/13/8-43-billion-in-sales-expected-for-allstate-corp-all-this-quarter.html.

Allstate Company Profile

The Allstate Corporation (Allstate) is a holding company for Allstate Insurance Company. The Company’s business is conducted principally through Allstate Insurance Company, Allstate Life Insurance Company and other subsidiaries. It is engaged in the property-liability insurance business and the life insurance, retirement and investment products business.

Get a free copy of the Zacks research report on Allstate (ALL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.